Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yulia Elkina"'
Autor:
Sandra Palus, Yulia Elkina, Tanja Braun, Stephan vonHaehling, Wolfram Döhner, Stefan D. Anker, Anthony Cerami, Michael Brines, Jochen Springer
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 4, Pp 2202-2210 (2022)
Abstract Background Cancer cachexia (CC) is a severe complication during the last stages of the disease, which is characterized by the substantial loss of muscle and fat mass. Currently, there is no effective treatment of CC. Erythropoietin plays tis
Externí odkaz:
https://doaj.org/article/7cecc6d28b3f45f4919338edfc4de23c
Autor:
Aleksandr Bulaev, Vitaliy Kadnikov, Yulia Elkina, Aleksey Beletsky, Vitaliy Melamud, Nikolai Ravin, Andrey Mardanov
Publikováno v:
Biology, Vol 12, Iss 11, p 1411 (2023)
In the present study, the effect of additional carbon sources (carbon dioxide and molasses) on the bio-oxidation of a pyrite–arsenopyrite concentrate at temperatures of 40–50 °C was studied, and novel data regarding the patterns of the bio-oxida
Externí odkaz:
https://doaj.org/article/1c3a865bc040451f8612f692175044fa
Autor:
Stefan D. Anker, Jochen Springer, Wolfram Doehner, John Beadle, Yulia Elkina, Kai Hartmann, Andrew J.S. Coats, Stephan von Haehling, Sandra Palus, Anika Tschirner, Ulrike Mayer
Publikováno v:
International Journal of Cardiology. 170:160-166
Cancer cachexia is thought to be the cause of20% of cancer related deaths. Symptoms of cancer cachexia patients include depression and anorexia significantly worsening their quality of life. Moreover, in rodent models of cancer cachexia atrophy of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65dfffb4bf6d8786cf9e91b098b4e939
https://doi.org/10.1016/j.ijcard.2013.10.022
https://doi.org/10.1016/j.ijcard.2013.10.022
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Myostatin is an extracellular cytokine mostly expressed in skeletal muscles and known to play a crucial role in the negative regulation of muscle mass. Upon the binding to activin type IIB receptor, myostatin can initiate several different signalling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8441863878cb58729891a291dbb09b4c
https://doi.org/10.1007/s13539-011-0035-5
https://doi.org/10.1007/s13539-011-0035-5